BIOAVAILABILITY OF METHAQUALONE

被引:15
作者
SMYTH, RD [1 ]
LEE, JK [1 ]
POLK, A [1 ]
CHEMBURKAR, PB [1 ]
SAVACOOL, AM [1 ]
机构
[1] WILLIAM H RORER INC, RES DIV, 500 VIRGINIA DR, FT WASHINGTON, PA 19034 USA
关键词
D O I
10.1002/j.1552-4604.1973.tb00185.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:391 / 400
页数:10
相关论文
共 25 条
[1]  
AKAGI M, 1963, CHEM PHARM BULL, V11, P321
[2]  
AKAGI M, 1963, CHEM PHARM BULL, V11, P62
[3]  
Amin A. H., 1970, PROG DRUG RES, V14, P218
[4]  
[Anonymous], 1971, STAT PRINCIPLES EXPT
[5]  
[Anonymous], 1970, CLARKES ISOLATION ID
[6]  
BARCELO R., 1961, CANADIAN MED ASSOC JOUR, V85, P1304
[7]   MEMBRANE ULTRAFILTRATION - DIAFILTRATION TECHNIQUE AND ITS APPLICATION TO MICROSOLUTE EXCHANGE AND BINDING PHENOMENA [J].
BLATT, WF ;
ROBINSON, SM .
ANALYTICAL BIOCHEMISTRY, 1968, 26 (01) :151-&
[8]   FLUORIMETRIC ASSAY OF METHAQUALONE IN PLASMA BY REDUCTION TO 1,2,3,4-TETRAHYDRO-2METHYL-4-OXO-3-O-TOLYLQUINAZOLINE [J].
BROWN, SS ;
SMART, GA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1969, 21 (07) :466-&
[9]  
COHEN Y, 1962, ARCH INT PHARMACOD T, V136, P271
[10]  
COHEN Y, 1965, THERAPIE, V20, P101